Evidence map›Paper›PMID 26628420›Full record

ArticleDiabetes care2016

Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study.

Mary E Lacy, Gregory A Wellenius, Mercedes R Carnethon, Eric B Loucks, April P Carson, Xi Luo, Catarina I Kiefe, Annie Gjelsvik, Erica P Gunderson, Charles B Eaton and 1 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. A call for better validation of opioid overdose risk algorithms.Journal of the American Medical Informatics Association : JAMIA · 2023
    Article
  6. Subtyping Social Determinants of Health inmedRxiv : the preprint server for health sciences · 2023
    Article
  7. Article
  8. Article
  9. Nomogram Model for Screening the Risk of Type II Diabetes in Western Xinjiang, China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Mary E LacyDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI mary_lacy@brown.edu.
Gregory A WelleniusDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI.
Mercedes R CarnethonDepartment of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Eric B LoucksDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI.
April P CarsonDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
Xi LuoDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI.
Catarina I KiefeDepartment of Qualitative Health Sciences, University of Massachusetts Medical School, Worcester, MA.
Annie GjelsvikDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI.
Erica P GundersonCardiovascular and Metabolic Conditions Section, Division of Research, Kaiser Permanente Northern California, Oakland, CA.
Charles B EatonDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI.
Wen-Chih WuDepartment of Epidemiology, School of Public Health, Brown University, Providence, RI Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, RI Division of Cardiology, Providence Veterans Affairs Medical Center, Providence, RI.
Brown University · USKaiser Permanente · USNorthwestern University · USProvidence VA Medical Center · USUniversity of Alabama at Birmingham · USUniversity of Massachusetts Chan Medical School · US

Funding

University of Massachusetts Center for Clinical Science and Translational SupplementUL1TR001453 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2015 to 2024
$39.0M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
University of Massachusetts Center for Clinical and Translational ScienceUL1TR000161 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2012 to 2015
$11.0M
The Role of Nontraditional Glycemic Markers in Diabetes and AlbuminuriaK01DK095928 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CARSON, APRIL P · 2013 to 2015
$406k
Effect of sickle cell trait status on diabetes prediction in African AmericansF31DK105791 · NIDDK · BROWN UNIVERSITY · PI LACY, MARY E. · 2015 to 2016
$87k
NCATS NIH HHS UL1 TR000161NCATS NIH HHS UL1 TR001453NHLBI NIH HHS HHSN268200900041CNHLBI NIH HHS HHSN268201300025CNHLBI NIH HHS HHSN268201300026CNHLBI NIH HHS HHSN268201300027CNHLBI NIH HHS HHSN268201300028CNHLBI NIH HHS HHSN268201300029CNIA NIH HHS AG0005NIDDK NIH HHS F31 DK105791NIDDK NIH HHS F31-DK-105791NIDDK NIH HHS K01 DK095928NIDDK NIH HHS K01-DK-095928NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

objectiveIn 2010, the American Diabetes Association (ADA) added hemoglobin A1c (A1C) to the guidelines for diagnosing type 2 diabetes. However, existing models for predicting diabetes risk were developed prior to the widespread adoption of A1C. Thus, it remains unknown how well existing diabetes risk prediction models predict incident diabetes defined according to the ADA 2010 guidelines. Accordingly, we examined the performance of an existing diabetes prediction model applied to a cohort of African American (AA) and white adults from the Coronary Artery Risk Development Study in Young Adults (CARDIA). RESEARCH DESIGN AND

methodsWe evaluated the performance of the Atherosclerosis Risk in Communities (ARIC) diabetes risk prediction model among 2,456 participants in CARDIA free of diabetes at the 2005-2006 exam and followed for 5 years. We evaluated model discrimination, calibration, and integrated discrimination improvement with incident diabetes defined by ADA 2010 guidelines before and after adding baseline A1C to the prediction model.

resultsIn the overall cohort, re-estimating the ARIC model in the CARDIA cohort resulted in good discrimination for the prediction of 5-year diabetes risk (area under the curve [AUC] 0.841). Adding baseline A1C as a predictor improved discrimination (AUC 0.841 vs. 0.863, P = 0.03). In race-stratified analyses, model discrimination was significantly higher in whites than AA (AUC AA 0.816 vs. whites 0.902; P = 0.008).

conclusionsAddition of A1C to the ARIC diabetes risk prediction model improved performance overall and in racial subgroups. However, for all models examined, discrimination was better in whites than AA. Additional studies are needed to further improve diabetes risk prediction among AA.

Indexed as

Black or African AmericanAdultArea Under CurveAtherosclerosisCohort StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansMaleMiddle AgedRisk AssessmentRisk FactorsWhite PeopleYoung AdultGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID26628420
PMCPMC4722943
OpenAlexW2189341928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.